Cervical Biopsy Articles & Analysis

1 news found

INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18

These endpoints were: a) regression of cervical HSIL to normal tissue combined with HPV-16/18 viral clearance, b) regression of cervical HSIL alone, c) regression of cervical HSIL to normal tissue, and d) HPV-16/18 viral clearance alone. ...

Mar. 1, 2021

ByINOVIO Pharmaceuticals

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you